Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immunoglobulin G - Biotest AG

Next Previous
Search
Drug Profile

Immunoglobulin G - Biotest AG

Alternative Names: BT 090; BT 681; Immunoglobulin liquid intravenous - Biotest AG; Intratect 10%; Intratect 100g/L; Intratect 5%; Intratect 50g/L; IVIG - Biotest AG

Latest Information Update: 27 Apr 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biotest AG
  • Class Immunoglobulin isotypes
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Agammaglobulinaemia; Guillain-Barre syndrome; Idiopathic thrombocytopenic purpura; Immunodeficiency disorders; Mucocutaneous lymph node syndrome
  • Phase III Pain

Most Recent Events

  • 25 Apr 2022 Biotest AG has been acquired by Grifols
  • 06 Jun 2017 No recent reports on development identified - Registered for Immunodeficiency disorders in Vietnam (IV,liquid,10%)
  • 01 Jan 2013 Merz Pharma acquires marketing rights for Intratect® in Russia, from Biotest AG

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top